Immulina as an Immunostimulatory Supplement: Formulation and Pharmacological Studies

Abstract

Immulina is a commercially available extract of Arthrospira platensis enriched with bacterial lipoproteins that acts as a potent Toll-like receptor 2 agonist. However, the immunostimulatory effect of Immulina is not well understood in vivo. Here, to devise an Immulina formulation suitable for in vivo oral gavage dosing, Immulina nanosuspension was prepared and freeze-dried to yield lyophilized nano-Immulina, which had an average particle size of around 300 nm and fully retained the bioactivity as a Toll-like receptor 2 agonist. Compared to the regular Immulina powder, lyophilized nano-Immulina notably accelerated the dissolution in aqueous media. Immulina nanosuspension was found to stimulate the production of proinflammatory cytokines in murine bone marrow-derived dendritic cells and macrophages. The immune response to Immulina was investigated in healthy mice by longitudinally monitoring the phagocytic activity of circulating neutrophils as a surrogate marker. Following daily oral ingestion of Immulina nanosuspension (10 mg/mouse/day), the phagocytic activity of circulating neutrophils was significantly elevated, suggesting an important mechanism for Immulina to enhance innate immunity.

Key words

Arthrospira platensis - Phormidiaceae - Immulina - TLR2 - dissolution - neutrophil - phagocytosis

Publication History

Received: 28 April 2023

Accepted after revision: 11 August 2023

Article published online:
30 August 2023

• References

• 1 Ciferri O. Spirulina, the edible microorganism. Microbiol Rev 1983; 47: 551-578
• 2 Calella P, Cerullo G, Di Dio M, Liguori F, Di Onofrio V, Gallè F, Liguori G. Antioxidant, anti-inflammatory and immunomodulatory effects of spirulina in exercise and sport: A systematic review. Front Nutr 2022; 9: 1048258
• 3 Gogna S, Kaur J, Sharma K, Prasad R, Singh J, Bhadariya V, Kumar P, Jarial S. Spirulina – An edible cyanobacterium with potential therapeutic health benefits and toxicological consequences. J Am Nutr Assoc 2023; 42: 559-572
• 4 Fais G, Manca A, Bolognesi F, Borselli M, Concas A, Busutti M, Broggi G, Sanna P, Castillo-Aleman YM, Rivero-Jiménez RA. Wide range applications of Spirulina: From earth to SPACE missions. Mar Drugs 2022; 20: 299
• 5 Jester BW, Zhao H, Gewe M, Adame T, Perruzza L, Bolick DT, Agosti J, Khuong N, Kuestner R, Gamble C. Development of Spirulina for the manufacture and oral delivery of protein therapeutics. Nat Biotechnol 2022; 40: 956-964
• 6 Pasco DS, Pugh ND, Elsohly M, Ross S, ElSohly NM. Potent immunostimulants from microalgae. US Patent 7 205 284, 2007
• 7 Nielsen CH, Balachandran P, Christensen O, Pugh ND, Tamta H, Sufka KJ, Wu X, Walsted A, Schjørring-Thyssen M, Enevold C. Enhancement of natural killer cell activity in healthy subjects by Immulina^®, a Spirulina extract enriched for Braun-type lipoproteins. Planta Med 2010; 76: 1802-1808
• 8 Balachandran P, Pugh ND, Ma G, Pasco DS. Toll-like receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in mice. Int Immunopharmacol 2006; 6: 1808-1814
• 9 Huh J, Zhang J, Hauerová R, Lee J, Haider S, Wang M, Hauer T, Khan IA, Chittiboyina AG, Pugh ND. Utility of fatty acid profile and in vitro immune cell activation for chemical and biological standardization of Arthrospira/Limnospira . Sci Rep 2022; 12: 1-13
• 10 Pugh ND, Edwall D, Lindmark L, Kousoulas KG, Iyer AV, Haron MH, Pasco DS. Oral administration of a Spirulina extract enriched for Braun-type lipoproteins protects mice against influenza A (H1N1) virus infection. Phytomedicine 2015; 22: 271-276
• 11 Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 2021; 6: 291
• 12 Fitzgerald KA, Kagan JC. Toll-like receptors and the control of immunity. Cell 2020; 180: 1044-1066
• 13 Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. Crystal structure of the TLR1–TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130: 1071-1082
• 14 Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S, Han SH, Lee H, Paik SG, Lee JO. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009; 31: 873-884
• 15 Kaur A, Baldwin J, Brar D, Salunke DB, Petrovsky N. Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics. Curr Opin Chem Biol 2022; 70: 102172
• 16 Nishida S, Tsuboi A, Tanemura A, Ito T, Nakajima H, Shirakata T, Morimoto S, Fujiki F, Hosen N, Oji Y. Immune adjuvant therapy using Bacillus Calmette–Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments. Medicine 2019; 98: e16771
• 17 Sun J, Rutherford ST, Silhavy TJ, Huang KC. Physical properties of the bacterial outer membrane. Nat Rev Microbiol 2022; 20: 236-248
• 18 Braun V, Rehn K. Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall: The specific effect of trypsin on the membrane structure. Eur J Biochem 1969; 10: 426-438
• 19 Chen YH, Chang GK, Kuo SM, Huang SY, Hu IC, Lo YL, Shih SR. Well-tolerated Spirulina extract inhibits influenza virus replication and reduces virus-induced mortality. Sci Rep 2016; 6: 24253
• 20 Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T. Activation of the human innate immune system by Spirulina: Augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis. Int Immunopharmaol 2002; 2: 423-434
• 21 Jog R, Burgess DJ. Pharmaceutical amorphous nanoparticles. J Phar Sci 2017; 106: 39-65
• 22 Chandler CE, Ernst RK. Bacterial lipids: Powerful modifiers of the innate immune response. F1000Res 2017; 6: F1000 Faculty Rev-1334
• 23 McAllister M. Dynamic dissolution: A step closer to predictive dissolution testing?. Mol Pharm 2010; 7: 1374-1387
• 24 Doyle SL, OʼNeill LA. Toll-like receptors: From the discovery of NF-κB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 2006; 72: 1102-1113
• 25 Grzanna R, Polotsky A, Phan PV, Pugh N, Pasco D, Frondoza CG. Immolina, a high-molecular-weight polysaccharide fraction of Spirulina, enhances chemokine expression in human monocytic THP-1cells. J Altern Complement Med 2006; 12: 429-435
• 26 Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001; 276: 37692-37699
• 27 Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: From mechanisms to disease. Ann Rev Immunol 2012; 30: 459-489
• 28 Németh T, Sperandio M, Mócsai A. Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov 2020; 19: 253-275
• 29 Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood 2003; 102: 2660-2669
• 30 Aroca-Crevillén A, Adrover JM, Hidalgo A. Circadian features of neutrophil biology. Front Immunol 2020; 11: 576
• 31 OʼBrien GC, Wang JH, Redmond HP. Bacterial lipoprotein induces resistance to Gram-negative sepsis in TLR4-deficient mice via enhanced bacterial clearance. J Immunol 2005; 174: 1020-1026
• 32 Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol 2014; 14: 667-685
• 33 Gustafsson JK, Johansson ME. The role of goblet cells and mucus in intestinal homeostasis. Nat Rev Gastroenterol Hepatol 2022; 19: 785-803
• 34 Gustafsson JK, Davis JE, Rappai T, McDonald KG, Kulkarni DH, Knoop KA, Hogan SP, Fitzpatrick JA, Lencer WI, Newberry RD. Intestinal goblet cells sample and deliver lumenal antigens by regulated endocytic uptake and transcytosis. Elife 2021; 10: e67292
• 35 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantification PCR and the 2^-ΔΔC _T method. Methods 2001; 25: 402-408